{
    "id": "dbpedia_5684_2",
    "rank": 83,
    "data": {
        "url": "https://www.froedtert.com/clinical-trials/open-label-multiple-dose-dose-escalation-study-investigate-safety-pharmacokinetics",
        "read_more_link": "",
        "language": "en",
        "title": "An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects with Solid Tumors or Lymphoma",
        "top_image": "https://www.froedtert.com/sites/default/files/styles/one_column/public/image/2018-07/social-froedtert-medical-college-wisconsin-facebook.jpg",
        "meta_img": "https://www.froedtert.com/sites/default/files/styles/one_column/public/image/2018-07/social-froedtert-medical-college-wisconsin-facebook.jpg",
        "images": [
            "https://www.froedtert.com/sites/default/files/2022-07/Froedtert%20and%20MCW%20w-outline_0.svg",
            "https://www.froedtert.com/sites/default/files/image/2020-03/Download_on_the_App_Store_Badge_US-UK_blk_092917.png",
            "https://www.froedtert.com/sites/default/files/image/2020-03/google-play-badge_0.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "The major purposes of this study are to determine the maximum dose of the study drug that can be tolerated in humans, and once this dose is found, if it has any effect in patients with solid tumors or lymphoma.",
        "meta_lang": "en",
        "meta_favicon": "/sites/default/files/favicon.ico",
        "meta_site_name": "Froedtert & the Medical College of Wisconsin",
        "canonical_link": "https://www.froedtert.com/clinical-trials/open-label-multiple-dose-dose-escalation-study-investigate-safety-pharmacokinetics",
        "text": "Protocol No\n\nVMONCOLOGY-VMO-01C\n\nPhase\n\nI\n\nSummary\n\nThe major purposes of this study are to determine the maximum dose of the study drug that can be tolerated in humans, and once this dose is found, if it has any effect in patients with solid tumors or lymphoma.\n\nDescription\n\nThis is a Phase 1 study of orally administered VMD-928 in adult subjects with advanced solid tumors or lymphoma that have progressed or are non responsive to available therapies and for which no standard or available curative therapy exists\n\nParticipating Institutions\n\nFroedtert Hospital\n\nStatus\n\nOPEN TO ACCRUAL\n\nClinicalTrials.gov\n\nWe use cookies to understand how you use our site and to improve your experience. By continuing to use our site, you accept the use of cookies. To learn more, including how to disable cookies, visit our Privacy Policy."
    }
}